Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials

• Autors principals: Toshiyuki Harada (Autor), Toraji Amano (Autor), Tomoo Ikari (Autor), Kei Takamura (Autor), Takahiro Ogi (Autor), Toshiaki Fujikane (Autor), Yuka Fujita (Autor), Kageaki Taima (Autor), Hisashi Tanaka (Autor), Takaaki Sasaki (Autor), Shunsuke Okumura (Autor), Shunichi Sugawara (Autor), Hiroshi Yokouchi (Autor), Noriyuki Yamada (Autor), Naoto Morikawa (Autor), Hirotoshi Dosaka-Akita (Autor), Hiroshi Isobe (Autor), Masaharu Nishimura (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2018-01-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

The herbal medicine rikkunshito has the potential to improve chemotherapy-induced nausea and vomiting (CINV) by stimulating ghrelin secretion. We aimed to evaluate the efficacy and safety of rikkunshito in preventing CINV for patients with lung cancer. Two separate prospective, randomized, phase II...